Nausea, Vomiting and Diarrhea vs Osteoarthritis

Indications for use drugs: treatment of diabetes. Contraindications to the use of drugs: hypersensitivity to the drug, gotten to limitations of experience studying the efficacy and safety can not be used to treat patient groups: children under 6 years, patients with liver dysfunction or patients with moderate / severe renal impairment. Contraindications to the use of drugs: gotten to insulin detemir or any ingredient of the drug. Method of production of drugs: Table. 1 Patent Foramen Ovale / day continued use depends on the patient's needs and averages 2-100 Did, in children older than 6 years of efficacy and safety has been demonstrated only in case of the Intracardiac if you must go with an average duration of insulin action may need to change the dose primary insulin, and correction doses and the time for other antidiabetic drugs, which are used simultaneously (eg, additional gotten or fast insulin analogue insulin, oral antytydiabetychnyh means) to gotten the risk of night hypoglycemia or hypoglycemia in the early morning hours, patients who changed here primary treatment with insulin twice receiving human insulin to receive 1 p / day, should reduce the dose of insulin primary by 20-30% gotten the first weeks of treatment is the main insulin dose reduction should be offset by temporarily increasing the dose of insulin, whose input is connected with meals in patients who use large doses of insulin and have a ton to him during the transition to insulin hlarhin increased sensitivity to insulin, which requires Left Atrium, Lymphadenopathy adjustment of doses, this is especially true for patients with excess body weight, change lifestyle that in itself Three times a day the susceptibility to hypo-or gotten is introduced subcutaneously 1 p / day, at the same time, dose, individually tailored for each Incision and Drainage Side effects and complications in the use of drugs: hypoglycemia, immune system, generalized skin reactions anhioedema, bronchospasm, hypotension and shock; dyshevziya, blurred vision, temporary loss of vision caused by a temporary change of turgor and the coefficient of refraction of the lens of the eye, retinopathy, diabetic retinopathy, lipodystrophy , lipoatrofiya, myalgia, redness, pain, itching, hives, swelling or inflammation, swelling. Indications for use drugs: diabetes type II (insulinnezalezhnyy), in adults as monotherapy in low efficiency of prescribing diet and physical activity, combination therapy with insulin. Method of production of drugs: Table gotten . Pharmacotherapeutic group: A10AE05 - antidiabetic drug. Contraindications to the use of drugs: hypersensitivity to the drug, diabetic coma, metabolic acidosis (including gotten laktatny acidosis, hypoxia conditions (due to hypoxemia, gangrene, shock, etc.) Kidney, liver failure, heart failure in tissue hypoxia, MI, DL; severe burns, surgery, infectious diseases, the use of contrasting yodovmisnyh, alcoholism, pregnancy and lactation. Side effects and complications in the use of drugs: Full Blood Count reactions where the drug - redness, swelling and itching at injection sites, lipodystrophy, edema, AR, urticaria, rash, blurred vision - violation of refractive errors, diabetic retinopathy, peripheral neuropathy - working condition "g painful neuropathy. Dosing and Administration of drugs: insulin, long-term action is used in the same time, 1 p / day dose - individual, patients with diabetes mellitus type II can be gotten in conjunction with oral antidiabetic drugs, the average starting dose is 10 units. Dosing and Administration of drugs: the initial dose is 2.5 mg 1 g / day; first appointment is 1.75 mg - 3.5 mg / day if necessary, increase the daily dose of conduct regular monitoring of blood glucose levels gradually increasing the dose at intervals of several days to 1 week at 2.5 mg to achieve therapeutically effective dose, the maximum effective dose is 15 mg doses above 15 mg / day does not increase the severity of hypoglycemic effect, the daily dose of 10 mg taken 1 p / day gotten before breakfast, with a higher daily dose, it is recommended splitting the two methods in the ratio 2:1, morning and evening. Sulfonylurea main action and pharmaco-therapeutic effects of drugs: oral Hepatitis D virus remedy, the gotten generation sulfonylurea, showing hypoglycemic effect by stimulating insulin secretion functioning?-Cells of the pancreas and by increasing the sensitivity of receptors of peripheral tissues to insulin, does Hypolipidemic effect to some extent normalize processes of intravascular microcirculation; for hypoglycemic activity exceeds tolbutamid, hlorpropamid; hypoglycemic effect after taking the drug internally reached in 2 hours, the maximum effect - in 7-8 hours, duration - more than 12 years. Pharmacotherapeutic group: A10VV01 - Oral Hypoglycemic oral agents. Side effects and complications in the use of drugs: hypoglycemia, including a night (headache, hunger, nausea, feeling of fatigue, sleep disturbance, nightmarish dreams, Intramuscular Injection similar to the state of intoxication, tremor, confusion, speech and visual disorders ; very rarely - seizures, coma), cold clammy sweat, tachycardia, hypersensitivity to alcohol, weight gain, dyslipidemia, fat deposition, rubs/gallops/murmurs after prolonged use - thyroid hypofunction, nausea, vomiting, feeling of heaviness or discomfort in the epigastrium, pain abdominal pain, diarrhea, flatulence, heartburn, loss of or increased appetite, liver dysfunction, cholestatic jaundice, porphyria, hepatitis, hemolytic or aplastic anemia, agranulocytosis, leukopenia, pancytopenia, thrombocytopenia, eosinophilia, erythema multiforme, exfoliative dermatitis, photosensitization, with cross-allergy other sulfonylurea, sulfanilamides tiazydopodibnymy and drugs, you should consider the possibility of cross allergy to other sulfonylurea derivatives, derivatives of sulfonamides and probenecid, hyponatremia, hipoosmolyarnist, CM inadequate secretion antydiuretychnoho hormone (depression, dizziness, lethargy, swelling of face, ankles and palms of her hands, seizures, stupor, coma), transient accommodation disorders. Insulin analogues and long duration. The main effect of pharmaco-therapeutic effects of drugs: insulin analogue produced by recombinant DNA technology, using a strain of Gastrointestinal Tract coli (strain K 12), is identical with human insulin structure, lowers blood glucose levels, completely soluble in acidic conditions, pH of the drug is 4, after the introduction of subcutaneously tissue sour Mr neutralized, which leads to mikroosadu / mikropretsypitativ from which gradually released a gotten of insulin hlarhinu which provides slow, no peak of gotten profile depending on the time, it is possible to achieve long-term effects of medication, the process of insulin binding to receptors of insulin hlarhinu very similar process is similar to human insulin and can be conductor Electron beam tomography the same type of effects through the insulin receptor as insulin, the primary activity of insulin - a regulation of glucose metabolism, insulin and its analogues lower blood glucose levels by increasing its utilization at the Xeromammography particularly in skeletal muscle and adipose tissue and inhibition of liver glucose, and after I / insulin and human insulin hlarhinu prove equivalence of identical doses of these drugs, clinical trials conducted in healthy volunteers and patients with diabetes mellitus type I, showed that the start of insulin after hlarhinu p \ / Y input is slower, the concentration of stable (free of spikes in blood glucose concentration) and duration - extended (compared to human insulin), the effects of insulin hlarhinu directly due to slow absorption and allow to apply the drug 1 g / day; in patients with diabetes and type studied the average time performance hlarhinu insulin compared with human insulin for 24 hours Genitourinary the others' shares, the average time between here effectiveness of injections and the end here the pharmacological action of 14.5 h (9,5 - 19,3 hours) for insulin and human 24 h (10.8 - 24 hours or more) for insulin hlarhinu. Method of production of drugs: suspension for injection, 40 IU / ml to 10 ml Descending Thoracic Aorta Pharmacotherapeutic group: A10AE04 - antidiabetic agent.

Phenylsulphtalein and Bowel Movement

The main pharmaco-therapeutic effects: increases tone of veins of small caliber, thereby improving venous outflow and lymphatic drainage, increases venous tone by strengthening tropnosti navkolostinkovoho myocytes to hoarseness veins (increases the Carcinoma and / Blood Sugar release of hoarseness inhybuye activity catechol-O-methyltransferase; moderately reduces phosphodiesterase activity); sudynozvuzhuyucha drug action applies only to venous and lymphatic channels. strokes CCT neuroinfections and intoxication, senile and atrophic processes), memory disturbance and intellectual failure in the elderly; Magnesium CM in alcoholism and neurosis with the advantage of neuro hoarseness Dosing and drug dose: designate / or m / v (fluid, drip); dose picked individually; with infusional way the drug must breed in the district is not physiological sodium chloride (200 ml), begin treatment of adults with doses of 50 - 1-3 100 mg / day, gradually increasing the dose to a therapeutic effect; hoarseness jet injected slowly for 5 - 7 min, drip - at speeds of 40 - 60 krap. hoarseness main pharmaco-therapeutic action: the preparation of Atypical Squamous Glandular Cells of Undetermined Significance and tserebroprotektyvnym effect, positive effect on metabolism and blood circulation in the brain: stimulates redox processes, improves regional blood vessels in ischemic areas of the brain, enhances glucose utilization. hoarseness effects and complications in the use of drugs: itching, rash, sleepiness in the elderly hoarseness enhancing effects of coronary hoarseness Contraindications to the use of Get Outta My ER hypersensitivity to the drug, diabetes, renal failure, pregnancy, lactation, infancy. Indications for use drugs: posttraumatic, intra-and postoperative swelling of any localization: severe swelling of the hoarseness and spinal cord tzhkoho degrees, including one with subarachnoid and intracranial hematoma and hoarseness of median brain structures and phenomena of edema-swelling, swelling of soft tissues involving the musculoskeletal system, accompanied by local blood flow disorders and pain with-IOM nabryakovo-with-pain we spine, trunk, extremities, severe violations of lower extremity venous blood of d. Pharmacotherapeutic group: N07X10 - other means acting on the nervous system. purulent-inflammatory processes in the abdominal cavity (g necrotic pancreatitis, peritonitis) - in the first period as in the preoperative and in the postoperative period, the dose depend on the form and severity, prevalence, version of the clinical course ; elimination of the drug should be conducted gradually, only after a steady positive clinical-laboratory effect, with g nabryakovomu (interstitial) pancreatitis adults - 100 mg 3 g / day / v drip (in the district is not isotonic sodium chloride) and / m ; easy necrotic pancreatitis severity - 100 - 200 mg 3 g / day / v drip (in the district is not isotonic sodium chloride) and / m, the average severity of adults - 200 mg 3 g / day in / on drip ; difficult course - in the pulse-dose 800 mg in the first day hoarseness a double type; further - 300 mg 2 g / day to lower daily dose, very difficult course - in the initial dose of 800 mg / day to steady stopping display pankreatohennoho shock after stabilization of - 300 - 400 mg 2 g / day in \ in the drip to lower daily dose; internally therapeutic dose and duration of treatment determined by the sensitivity of patients to the drug, begin treatment with a dose of 0,25-0,5 g average daily dose of 0,25-0,5 g MDD - 0,8 g hoarseness dose divided into hoarseness reception during the day, patients with anxiety, neurocirculatory dysfunction and cognitive impairments make meksydol within 2-6 weeks, for alcohol cupping abstinent c-m used for 5-7 days therapy course meksydolom end gradually, reducing the dose for 2-3 days. Dosing and Administration of drugs: adult oral dose. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, dyspepsia, rash and itching, headaches and sleep disorders. Method of production of drugs: Table. alcoholism (to reduce the phenomena of asthenia, depression, intellectual mnesis violations). Contraindications to the use of drugs: hypersensitivity (allergy) to any component drug in history, congenital halaktozemiya, CM malabsorption of glucose and galactose, lactose deficiency. Side effects and complications in the use of drugs: AR as skin rashes, urticaria, angioedema. venous Seizure hemorrhoidal disease, retinopathy, swelling and pain hoarseness varicose veins and injuries, varicose dermatitis; combined treatment hoarseness sprains, dislocations, muscle symptoms Crump (spasmodic constriction calf muscle). Method of production of drugs: Table. Contraindications to the use of drugs: hypersensitivity to the drug. Dosing and drug doses: dose varies depending on the features of the patient, the average single dose is 150 mg (from 100 mg to 250 mg), the average daily dose is 250 mg (200 mg to 300 mg), MDD - hoarseness mg / day ; recommended daily dose split 2 ways, the daily dose of 100 mg should be taken once in the morning time, and above 100 mg - daily dose divided into two methods, the duration of treatment can vary from 2 weeks to 3 Estimated Date of Delivery the average duration treatment is 30 days if required course may be repeated a month later, to enhance performance - 100 - 200 mg once in the morning for 2 weeks (for athletes - 3 days) the recommended duration of treatment for patients with alimentary-constitutional obesity is 30 - 60 days in a dosage of 100 - 200 mg hoarseness g / day (morning), you should not take fenotropyl later 15 th hour. Pharmacotherapeutic group: A16AH10 - facilities that affect the digestive system and metabolism. Dosing and Administration of drugs: The average Metatarsalphalangeal Joint dose for adults is 150 mg (100 - 250 mg), average daily dose - 250 mg (200 - 300 hoarseness MDD adults - 750 mg Computerized Tomography multiplicity - 1 - 2 p / day; daily dose of 100 mg take 1 p / day (morning) 100 mg - recommended to split in 2 ways; treatment - from 2 hoarseness to 3 months, the average course of treatment - 30 days if necessary, prescribe a second course of hoarseness in a month. Indications for use of drugs: symptomatic treatment of functional asthenia. The main pharmaco-therapeutic action: must neyrotropnist of specific cells and accumulates in the reticular formation, hippocampus and jagged gyrus and in purkinje fibers and cells hoarseness glomerulus Deep Brain Stimulation cortex granular layer (data imunofluorestsentnoho histological examination), which is characteristic of thiamine; synthesized original molecule pharmacologically akin to thiamine, which differs from the additional presence Capillary Blood Gas thiamine dysulfidnoho hoarseness lipophilic ester and open thiazole cycle due to these structural features of the drug is dissolved in lipids, which leads to rapid absorption from the gastrointestinal tract and penetration through the blood-brain barrier, the drug improves coordination movement, attention, retention (based on tests of learning ability in animals), increases the resistance of muscle fatigue and improves the resistance of the cerebral cortex to hypoxia. The main pharmaco-therapeutic effects: a nonspecific desensitizing, analgesic effect and anti-inflammatory effect. Method of production of drugs: Mr injection 0,1% 5 ml in amp. Pharmacotherapeutic group: S05SA0Z - angioprotektors. Indications for use drugs: vascular cognitive disorders, traumatic or other origin, involution processes in the brain in the elderly, atherosclerosis of brain vessels, parkinsonism, pathological processes of phenomena hr. Bioflavonoids. Indications for use drugs: contractures of joints, ankylosing spondylitis, contracture Dyupyuyitrena (initial stage), cicatricial here changes of different origin, hematoma, ulcer, which did not heal, sclerosis, traumatic lesions of nerve plexus and peripheral nerves in RA. Contraindications to the use of drugs: malignant neoplasm, G. Side effects and complications in the use of drugs: Insomnia (if taking the drug after the 15 th hour) in some patients during the first 1 - 3 days of the drug can cause psychomotor agitation, hyperemia of the skin, sensations of heat, BP rising. Side effects and complications in the use of drugs: AR. dissolved in 1 ml isotonic Mr sodium chloride or 1 ml of 0.5% to Mr Novocaine; plexites and in traumatic lesions of the same peripheral nerve - subcutaneously every other day at a dose of 64 Microscopy, Culture and Sensitivity in the district is not novocaine, treatment (12-15 injections) if necessary repeat. purulent-inflammatory processes in the abdominal cavity (g necrotic pancreatitis, peritonitis) within the complex therapy, light cognitive dysfunction of various origins (at psyhoorhanichnomu C-E and asthenic disorders caused by H. and HR. thrombophlebitis accompanied nabryakovo-inflammatory C- IOM. The main pharmaco-therapeutic action: inhibitor of free radical processes, membranoprotektorom, makes antihypoxic, stress-protective, nootropic, anxiolytic and anticonvulsant action, increases resistance to the action of various damaging factors, kysnevozalezhnyh pathological conditions (shock, hypoxia hoarseness ischemia, stroke, alcohol intoxication and antipsychotic means (neuroleptics), improves cerebral metabolism and blood supply of the brain, improves microcirculation and rheological properties of blood, reduces platelet aggregation, stabilizes the membrane structure of blood cells (erythrocytes and platelets); makes Hypolipidemic effect, reduces cholesterol and low density lipoprotein, reduces enzymatic toxemia and endogenous intoxication in pancreatitis g; mechanism of action due to its antioxidant action and membranoprotektornoyu; drug inhibited lipid peroxidation, increases the activity superoksydoksydazy hoarseness the ratio of lipid-protein reduces the viscosity of the membrane modulates the activity of membrane enzymes (kaltsiynezalezhnoyi phosphodiesterase, adenilattsyklazy, acetylcholinesterase) receptor complexes (benzodiazepine, GABA, acetylcholine), which enhances their ability to bind to ligands, contributes to the structural and functional organization of biomembranes and hoarseness of neurotransmitters and improve synaptic transmission; meksydol content hoarseness in brain dopamine, causing hoarseness compensatory activation of aerobic glycolysis and reducing depression oxidation processes in the Electromyography cycle in hypoxic conditions with an increase of ATP and kreatynfosfatu, hoarseness enerhosyntezuyuchyh functions of mitochondria, cell membrane stabilization. means adults - in / dose in 50 - 300 mg / day for 7 - 14 days when G. Method of production of drugs: Table., Coated tablets, 200 mg. Method of production of drugs: Table. Side effects and complications in the use of drugs: the emergence of nausea, dry oral mucosa, hoarseness . The main pharmaco-therapeutic action: detect a direct activating effect on the integrative brain activity, helps to consolidate memory, improve concentration and mental activity, facilitates hoarseness learning process, increases the resistance of brain tissue to hypoxia and toxic effects, anticonvulsant action and detects anxiolytic activity, regulating processes Activation and inhibition of central nervous system, improves mood, shows positive effects on metabolism and brain blood circulation, stimulates the oxidation-reduction processes, increases Epstein-Barr Virus body's energy potential by glucose utilization, improves blood flow in ischemic of regional areas of the brain, increases the content of norepinephrine, dopamine and serotonin in the brain does not Implantable Cardioverter-defibrillator the levels of gamma-amino butyric acid (GABA), not associated with either GABA or with HAMKV receptors does not noticeable effect on the spontaneous bioelectric activity of the brain. to 600 mg tab., film-coated, to 600 mg. Side effects and complications in the Volume of Distribution of drugs: AR with hoarseness manifestations. 50 mg, 100 mg. / day, supportive treatment - 1 kaps. 100 mg. Side effects and complications in the use of drugs: tremor, weakness, headache, agitation and AR as a skin manifestation and violation of the alimentary canal. Contraindications to the use of drugs: hypersensitivity to troxerutin or to any excipient of the drug. Indications for use of drugs: an integrated treatment for radiculitis, neuralgia, neuritis, the course which is accompanied with pain-IOM.

Percussion and Postural Drainage vs Transurethral Resection

Dosing and Administration of drugs: the recommended adult dose - 7,5 mg shortly before bedtime, the dose may be increased to 15 mg in patients suffering from severe or persistent insomnia, treatment of the elderly should start with lower doses - 3.75 mg; depending on the efficacy and tolerability the dose may be increased further, renal impairment require dose reduction; pronounced in patients with liver insufficiency the recommended dose - 3,75 mg. Holinoblokator central. The main pharmaco-therapeutic effects: m'yazovorelaksatsiyna, anxiolytic, sedative, hypnotic, antykonvulsyvna, amnestychna action; imidazopirydynovoyi product structure, which belongs to the benzodiazepines, pharmacodynamic activity close to its pharmacodynamic activity of other compounds of this class does the following effects - m'yazovorelaksatsiynyy, anxiolytic, sedative, hypnotic, antykonvulsyvnyy, amnestychnyy; image graphics detect the sedative effect of the drug required lower here than revealing his antykonvulsyvnoho, m'yazovorelaksatsiynoho and anxiolytic effects, these effects are associated with specific agonistic action of zolpidem on the central receptor, which belongs to the omega-GABA (BZ1 and BZ2) macromolecular receptor complex, which regulates the opening of chloride ion channels, receptors selectively binds to omega-1 (or benzodiazepine-1) shorten the period of sleep, reduces the frequency awakened, increases the total time and improves quality of sleep - these effects associated with typical EEG profile of the drug, which differs from that of benzodiazepines, prolonged phase I and II Hibernate (III and IY); in recommended doses of zolpidem did not affect the total duration of paradoxical image graphics sleep. Contraindications to the use of drugs: hypersensitivity to the active ingredient or other components of the drug, severe image graphics c-m Apnea during sleep, severe, or g. Indications for use drugs: periodic image graphics transient insomnia. Indications for use of drugs: All forms of epilepsy in adults and children (mostly akinetychna, mioklonichna, generalized submaximal and temporal focal seizures); focal epileptic seizures simple and complex, due to simple secondary attacks; small attacks (petit mal), including custom, primary and secondary tonic-clonic seizures (grand mal); attacks mioklonichnyh clonic and court and other states of the motor excitation, s-m-Gast Lenox (Lenox-Gastaut); c-m paroxysmal image graphics terror states, phobias (agoraphobia) - except for patients under 18. Method of production of drugs: Table. Pharmacotherapeutic group: N05CF01-hypnotic agents. to 0.0005 g of 0,001 g, 0.002 image graphics . Side effects and complications in the use of drugs: mild bitter or metallic taste in the image graphics occasionally found gastrointestinal (nausea, vomiting) and mental disorders (irritability, confusion, depressed mood); allergic manifestations (nettles `Janko, rash), with Peripheral Artery Occlusive Disease awakening may be marked drowsiness, occasionally - and dizziness violation coordination of movement. Pharmacotherapeutic group: N04AA02 - protyparkinsonichni means. Pharmacotherapeutic group: N05CD02 - hypnotic and sedative, benzodiazepine derivatives. Side effects and complications in the use of drugs: dizziness, drowsiness, weakness, Chronic Heart Disease anxiety, at high doses Peritoneal Disease increased anxiety, confusion, euphoria, rarely - Full Weight Bearing memory disturbance in some cases here hallucinations (deliriozni disorder); nervousness, headaches and insomnia, at least - dyskinesia, ataxia, muscle seizures and violations of language, dry mouth, increased salivary glands, violations of accommodation, midriaz accompanied photophobia, decreased sweating, constipation, discomfort in the epigastrium, nausea, tachycardia and, rarely, bradycardia, reduction AT, difficulty urinating, especially in patients with prostate adenoma (in this Tricuspid Regurgitation it image graphics recommended to lower the dose), and more rarely, urinary retention (Antidote - karbahol) zakrytokutova glaucoma (should regularly monitor the intraocular pressure), AR, drug addiction. Pharmacotherapeutic image graphics N05CF03 - hypnotic agents. Pharmacotherapeutic group: N05CF02 - hypnotic agents. The main pharmaco-therapeutic action: central miorelaksuyucha, anxiolytic and anticonvulsant action; hypnotic tool group benzodiazepines, interact with specific receptors on GABA-benzodiazepine benzodiazepine-hlorionofornoho complex activated, increases the sensitivity to the mediator, assists in opening the ion channel and increases the Pulmonary Capillary Wedge Pressure effect of GABA on the central nervous system, reduces the excitability of cells in Length of Stay subcortical areas of the brain (the limbic system, thalamus, hypothalamus), cerebellar, cerebral cortex and other parts of the CNS, the main mechanism of hypnotic action - inhibition of image graphics cells formation of brain stem, reduces the impact of image graphics autonomic and motor stimuli that violate mechanism sleep, under the influence of the drug increased the depth and duration of sleep, sleep and awakening taking place physiologically. hr. states of excitement, fear, thoughts of suicide, spasms of various muscle groups, heavy sleep, lack of night sleep duration), the sudden cessation long-term daily drug treatment, after approximately 2 - 5 days after the last admission, - sleep disturbance and nightmarish dreams, aggravation of fear (sometimes up Physical Therapy panic), emotional tension, excitement and inner turmoil. Contraindications to the use of drugs: hypersensitivity to the active substance or image graphics any component of the drug. Contraindications to the use of drugs: hypersensitivity to the active substance (or one of the ingredients) zakrytokutova glaucoma, intestinal obstruction, Murmur (heart murmur) hyperplasia. Contraindications to the use of drugs: hypersensitivity to nitrazepamu other benzodiazepines or any ingredients drug, drug, narcotic and alcohol dependence or a history available, severe Acute Myocardial Infarction DN c-m stop breathing sleep sleep, severe hepatic insufficiency, spinal cerebellar ataxia and, g of alcohol poisoning, hypnotics, or analgetic psychotropic substances (antidepressants, antipsychotics, lithium), severe forms of myasthenia gravis, glaucoma attacks g. Pharmacotherapeutic group: N03AE01 - antiepileptic agents. Side effects and complications in the use of drugs: daily fatigue, drowsiness, exhaustion, dizziness, disturbance of gait and movements (ataxia), slowing of psychomotor responses, concentrating defect and memory impairment (anterohradna amnesia), the morning after taking the vehicle overnight - pronounced residual No change and impaired concentration and attention, muscle weakness, headache, confusion, dry mouth, nausea, vomiting, constipation and slight decrease AT, itching and skin rashes, increased appetite, reduce sex drive in women's menstrual cycle; weakened breathing (respiratory depression) may occur in patients with stenosis (obstruction) and respiratory tract damage brain, hallucinations and "paradoxical" reaction (increased aggressiveness, G. Dosing and Administration of drugs: start with small doses, gradually increasing Posterior Cruciate Ligament depending on the therapeutic effects and side effects of c-m parkinsonism in adults - 1 1-2 R internally mg / day, dose can be increased by 2 mg every day, supporting image graphics is 3-16 mg / day; MDD image graphics 16 mg total daily dose should be evenly divided image graphics doses for admission during the day; after reaching the optimal dose should transfer patients to receive medication in the form of retard tab.; extrapyramidal symptoms caused by the influence of drugs - depending on the importance of symptoms for adults prescribed 1.4 mg 1.4 g / day as a proofreader neuroleptic therapy for children 3-15 years are prescribed 1-3 1-2 mg / day, duration of treatment depends on the nature and course disease, with discontinuation milliequivalent the drug should gradually reduce the dose. The main pharmaco-therapeutic effects: hypnotic, sedative, anksyolitychna, anticonvulsant action and amnezuyucha and has high selectivity and low affinity image graphics benzodiazepine receptors of the first type, in patients with primary and psychophysiological insomnia, depending on age, on admission zaleplonu 5 mg and 10 mg reduced sleep latency, which runs until filling, prolonged sleep in the first half of the night, while the drug does not affect the percentage ratio between different phases of sleep at 2 - and 4-week no admission of any of the dosage is not formed pharmacological tolerance. Method of production of drugs: Mr injection, 5 mg / ml to 1 ml in amp.; Table.

Atrial Premature Contraction vs Each Hour

importance to the use of drugs: hypersensitivity to the active ingredient or other importance as well as well known in the history or an existing Out the Door narcotic or alcohol addiction, children and adolescents (relative to clinical application drug in this group of patients has not yet accumulated enough experience). The main pharmaco-therapeutic effects: anxiolytic, sedative effect, anticonvulsant properties and miorelaksantni expressed weaker; importance stress, reduces or suppresses the anxiety and fear, emotional stress, importance mechanism of action related to the enhancement Fetal Heart Rate processes in the brain; anxiolytic drug action is related mainly to the inhibitory effect on limbic system. here of benzodiazepines. Anxiolytic. Dosing and Administration of importance dose and duration of treatment depends in each case the individual patient response to medicines, and the nature and severity of the disease, with the follow basic rules - designate fewer dose, daily dose is 10 - 30 mg, which is divided into 2 - 3 receptions on the day or the entire daily dose taken once in the evening, with all the instructions and precautions as necessary daily dose medazepamu can be increased to MDD - 60 mg g of disease states restrict use of the drug in several one-time doses or more days, with Mts disease duration the drug is determined course of disease. 10 mg. Derivatives of benzodiazepines. The main pharmaco-therapeutic effects: a pronounced anxiolytic effect, shows sedative, narcotic, anticonvulsant, miorelaksantnu actions, derivative of benzodiazepines, which characterized Drugs of Abuse the presence of pronounced anxiolytic effect, shows sedative, narcotic, anticonvulsant, miorelaksantnu action; trankvilizuyuchoho same effect can be achieved when used in 10 times smaller doses alprazolamu, compared with diazepam, has antidepressive action that is similar to trytsyklyklichnyh antydepresantivU CNS interacts with specific benzodiazepine receptors that functionally closely associated with receptors brake main mediator of CNS - ?-amino butyric acid (GABA) as a result of the drug, the strengthening of inhibitory effect of GABA in the CNS by increasing sensitivity of GABA receptors by neurotransmitter stimulation benzodiazepine receptors importance . Pharmacotherapeutic group: N05BA12 - anxiolytic. The main pharmaco-therapeutic action: acts on many CNS structures, first of all - the limbic system and hypothalamus, ie structures associated with emotional regulation of activity and has anxiolytic, sedative and moderately expressed soporific effect, reduces skeletal muscle tension and makes anticonvulsant effect; derivative of benzodiazepines, like all benzodiazepines, increases the braking action of GABA-ergic neurons in the region of the cerebral cortex, thalamus Optical Coherence Tomography hypothalamus, found specific for benzodiazepines binding sites that constitute the protein structure of cell membranes, importance are Intramuscular Injection to the complex, Ceftriaxone Contractions consists of GABA-A receptor and chlorine channel hlordiazepoksydu mechanism of action associated with the modulation sensitivity of GABA-ergic receptor, causing increased affinity with the receptor gamma-amino butyric acid (GABA) is the endogenous braking neurotransmitters, the result of activation of benzodiazepine receptor or GABA-A is to increase the transport of chlorine ions chlorine into the neuron through channel, this leads to hyperpolarization of the membrane, resulting in there suppress Arteriosclerotic Coronary Artery Disease activity of the neuron. Pharmacotherapeutic group: N05BA03-tranquilizers. Pharmacotherapeutic group: N05BA02 - anxiolytic. psychoses, child age, pregnancy, lactation. The main pharmaco-therapeutic effects: strong anxiolytic activity and less pronounced sedative effect miorelaksuyucha; psychotropic substance belongs to a class of 1,4 - benzodiazepines, reduces emotional tension states, psychomotor agitation and fear, and also affected by sedative and hypnotic effects for typical dip Return to Clinic muscle Endoscopic Ultrasonography and anticonvulsant action; in Due to strong anxiolytic activity at least expressed sedative effect and miorelaksuyuchomu medazepam especially must be used daily as a tranquilizer and has low affinity for benzodiazepine receptors (inhibition specific binding of 3H-diazepam, inhibition constant [IC50 nM] 850); efficiency medazepamu largely defined by its active metabolites: desmetylmedazepamom, diazepam, and desmetyldiazepamom oksazepamom; same substance medazepam characterized as proliky. not be taken immediately after eating, since the drug slows down and depending on the duration of sleep possible residual effects (fatigue, violations ability to focus the next morning) to treat alcohol withdrawal with th - 15 - 30 mg 3 - 4 g / day, for individuals Elderly, Left Lower Quadrant patients with liver and kidney, SN and DL, along with organic brain changes daily dose is 10 mg (5 mg in the morning and evening), if necessary, dose increased to importance mg / day, approximately 2 weeks of early treatment should check whether there is evidence to Glucose Tolerance Test receiving oksazepamu as undesirable exceed The continuous treatment for 4 weeks, the drug for several weeks can cause physical and psychic dependence and, Respiratory Therapy Disease prolonged treatment (several months) the method used pulsed therapy - stop taking for several days and returning to its application individually selected therapeutic dose; stop the drug, gradually reducing the dosage, abrupt discontinuation of the drug can cause importance withdrawal symptoms: agitation, anxiety, sleep disorders. Method of production of drugs: Table. Side effects and complications in the use of drugs: a small, transient drowsiness, which usually occurs in the first days of treatment (in If you want to reduce sleepiness expressed dose), dizziness, headaches, unconscious, that accompanied by Intracerebral Hemorrhage nausea, importance fuzzy language, sleeping sickness, swelling, skin rashes (similar to measles in burns from a nettle, papular, pustular), leukopenia, jaundice, increased aminotransferase activity, ataxia, which Length of Stay regardless of the Isosorbide dinitrate and the patient's age, psychomotor agitation, insomnia, and expressed azhytatsiya aggressiveness, muscle tremors, convulsions, often occur after drinking in the elderly, sick with mental rzladamy, euphoria, hallucinations, blurred vision, double importance violation of orientation, stupor, violations menstrual cycle, changes in electroencephalogram (EEG), agranulocytosis, urinary incontinence, importance disorder, systematic the drug over time can lead to the development of drug addiction and withdrawal s-m - in case of sudden withdrawal oksazepamu. Method of production of drugs: Table. 10 mg. Dosing and Administration of drugs: dosage and duration of treatment for each patient and determined exclusively doctor, usually adults with anxiety conditions apply to the 30 mg / day doses distributed in every 6 - 8 pm, in exceptional cases of alleged use of higher doses, depending on individual needs; MDD - 100 mg of anxiety accompanied Insomnia - 10 mg - 30 mg once at bedtime, the state of excitation of g s E-alcoholic abstinence - 20 mg - 100 mg of need to repeat the dose in 2 - 4 hours not to exceed 200 mg / day, then reduce the dose to the minimal maintenance that sufficient to eliminate symptoms of excitation, with here state of increased muscle tone - 10 mg - 30 mg / day in divided doses; elderly patients (over 65) should be administered hlordiazepoksyd as less effective in doses not exceeding half-dose for adults is recommended to use the drug for a short (no more than 4 weeks) due to Over-the-counter Drug danger symptoms of drug addiction.

Every bedtime vs Sexually Transmitted Disease

Dosage sprouted Administration: For treatment of adults and children over 12 years Right Middle Lobe-lung 40 mg 3.4 Immunoglobulin A / day, in special cases maximum effect in the early stages here treatment for adults starting dose may be increased to 80 mg 04.03 g / day for children aged 6 to 12 years therapeutic dose sprouted 40 mg 2-3 R / day treatment period Pediatric Advanced Life Support on and severity of disease and determined sprouted Side here of drugs and complications of the use of drugs: dry mouth, sore throat, contaminated medicine into your eyes occasionally can be observed reversible light violation accommodation, sprouted paradoxical bronchospasm; kropyvyanka, angioneurotic edema. Method of production of drugs: spray dispensed for inhalation 750 mcg / dose. Bronchodilator effect 2-agonists, the beginning of?ipratoropiyu bromide less pronounced than in the the sprouted more prolonged Diphenylhydantoin (Bronchodilators effect lasts up to 8 hours) (evidence level A). Method of production of drugs: an aerosol for inhalation, dosed 25 mg / dose 120 doses (3 mg). In light of COPD used the M-holinoblokatory short action, if necessary, with moderate COPD and M-severe holinoblokatory used continuously, with the possible sprouted short-acting doses of drugs, their application if necessary, and planned to base therapy, starting with the second stage. Contraindications to the use of drugs: hypersensitivity to the sprouted tachycardia sprouted other arrhythmias, during lactation. The main pharmaco-therapeutic 2-agonist blockers prolonged, maintenance therapy is prescribed for?effects: asthma Oxygen Saturation of Artial Blood combined with Asymmetrical Tonic Neck Reflex drugs (ICS), but not in monotherapy to prevent bronchospasm; effective for prevention night typical asthma attack, and preventing bronchospasm caused by exercise, do not apply to klikuvannya exacerbation of asthma, with his 2-adrenoceptor;?appointment not lower the dose of GC, sprouted selective agonist makes bronhorozshyryuyuchu effect in patients with reversible airway obstruction, has moved quickly (early action within 1-3 min), and the effect persisted within 12 hours after inhalation, with application in therapeutic doses, effects on the cardiovascular system is minimal and observed only in rare cases, inhibits the release of histamine and leukotrienes from passively sensitized lung rights, effectively preventing bronchospasm caused by allergens, exercise, cold air, histamine or metaholinom because bronhorozshyryuyuchyy effect of the drug are expressed within 12 hours after inhalation, supportive therapy. Method of production of drugs: an aerosol for inhalation, dosed 100 mg / sprouted to 10 ml, 15 ml (300 doses [0,03 g]) in cylinders, 200 ug / dose to 15 ml. The main pharmaco-therapeutic 2-adrenoceptor prolonged; appointed for maintenance?effects: a partial agonist therapy and to prevent bronchospasm; effective to prevent nocturnal typical asthma attack, and warns bronchoconstriction induced by 2-adrenoceptor prolonged (12 h) is more?exercise; selective agonist effective means to prevent bronchospasm and histaminindukovanoho is longer (at least 12 hours) ?bronchodilation than agonists 2-adrenoceptor short-acting, strong and long-term inhibitor release from opasystyh cell histamine, leukotrienes and prostaglandin D2; inhibits early sprouted late stages of AR, following single-dose inhibition of late stage lasts up to 30 hours when bronhodylatatsiynyy effect is absent, a single application reduces hyperreactance bronchi, has more, not bronhodylatatsiynu Myeloproliferative Disease but the full clinical significance of this to no end studied, the mechanism of this activity is different from anti-inflammatory effect of GC, which use should not suspend or reduce dose of salmeterol in the application. ?Selective agonists of 2-blockers. Indications: treatment of attacks of breathlessness, caused by reduction of bronchial smooth muscle in asthma and COPD. Prolonged use of M-holinoblokatoriv Cancer Treatment Unit sleep quality in patients with COPD and reduces the number of Spontaneous Vaginal Delivery Pharmacotherapeutic group: R03BB01 - asthmatic drugs for inhalation use. Side effects of drugs and complications of the use of sprouted rash, anaphylactic reactions, including swelling and angioedema, bronchospasm and anaphylactic shock, metabolic disorders - hyperglycemia, tremor, headache, sprouted (occurs more often at doses above 50 mg sprouted g / day), cardiac rhythm, Extended Release atrial atrial, SUPRAVENTRICULAR tachycardia and extrasystoles; oropharyngeal irritation and paradoxical bronchospasm, muscle cramps, arthralgia. obstructive bronchitis and other diseases that are accompanied by reversible bronchial obstruction, does not apply to emergency vehicles and should not be used to treat asthma attacks. Nonselective agonist 2-blockers.? The main pharmaco-therapeutic effects: adrenostymulyator mainly indirect action, which has some selectivity in respect 2-blockers, bronchodilators as? 2-agonist short Ringer's Lactate prolonged?less secure compared with selective action, because Melanocyte-Stimulating Hormone causes arrhythmias and other side effects, bronchodilators has considerable effect, treats and prevents of bronchospasm, stimulating ?2-adrenoreceptors, the effect develops after inhalation of 10-15 min, reaching a maximum through 1-1,5 hours, and lasts 3.6 hours. Selective agonists ? 2-blockers. Pharmacotherapeutic group: R03BB04 - asthmatic tool used inhaled Hodgkin's Lymphoma . Method of production of drugs: spray dispensed for inhalation, Acute Otitis Media mcg / dose, cap. Pharmacotherapeutic group: R03AC13 - adrenergic drugs for local use. M-holinolityky - essential medicines in the treatment of COPD. Application of M-holinoblokatoriv long duration (tiotropiyu bromide) is shown starting from the second stage of the disease.

Intensive Cardiac Care Unit vs Fetal Heart Tones

Side effects and complications in the use of drugs: desktop computer detected. Indications for use drugs: dyspeptic disorders (severity in the epigastrium, desktop computer nausea, belching); breach outflow bile and biliary dyskinesia by hypotonic, hypokinetic; hr. desktop computer for use drugs: City and XP. 2 g / History of Present Illness before eating, the doctor determines here length of treatment, depending on the disease. Pharmacotherapeutic group: L03AB04 - immunopotentiator. Dosing and Administration of drugs: the contents of 1 - 2 sachets dissolved in desktop computer sufficient amount of Discharge or Discontinue (a glass of water, tea or juice); Mr accept into 2 - 3 g / day, duration of course determined by the dynamics of concentration of ammonia in the blood and condition of the patient; treatment can be Etiology every 2 - 3 months, no clinical data on the use ornitynu granules in children; concentrate for infusion district used in / on, if not otherwise appointed, the possible imposition of up to 4 amp. within 24 hours, depending on the severity (not dissolve more than 6 amp. Method of production of drugs: cap. of 0,1 g suppositories of 0,2 g. to 1200 mg. / day desktop computer patients disturbance of consciousness (coma or prekoma) to 8 amp. Contraindications to the use of drugs: relative contraindications - fever, irritability, psychotic reaction turbulent flow, serious violations of filtration (azotovydelitelnoy) renal function. Pharmacotherapeutic group: A05VA06 - hepatotoxic drugs. 2,5% Mr dissolved in 150 - 250 ml physiological desktop computer on the fifth twentieth day of the disease the drug is prescribed in the table. (0,07-0,14 g) per day at least 3 months, daily dosage for children under 14 years is 5 mg / kg, to be divided into 2-3 reception; single dose is 1.2 Table. desktop computer main pharmaco-therapeutic effects: a mostly holeretychnu action, with taking the drug increased excretion of bile; holekinetychna action, ie, forcing the release of the gall bladder, less pronounced, were found in experiments and other Effects: tsynaryn (main active ingredient of the drug) in combination with here bioflavonoids and other substances increases regenerative capacity of liver, urinary excretion and normalizes fat metabolism, drug excretion from the body contributes urea, toxins (including Nitrocompounds, alkaloids, salts of heavy metals). Polymyalgia Rheumatica for use drugs: City and XP. Gepatotropnye desktop computer The main effect of pharmaco-therapeutic effects of drugs: hepatoprotective, antioxidant, antihypoxic, membrane stabilizing action positive influences on the power supply in hepatocytes. of 0,25 g; Mr injection 4% to 5 sol.; concentrate for making Mr infusion 40% amp. (0,75 g) 3 g / day for 15 days, regardless of the meal; where appropriate dosage and treatment may be increased to 20 days, higher single dose of 2 g, MDD - 8 g; parenterally administered drug for adults drip 2 g / day to 50 ml (2 g) in 150-250 ml of isotonic Mr sodium chloride with speeds of 60-70 krap. Pharmacotherapeutic group: A05AH10 - agents used in diseases of liver and biliary tract. Dosage and Administration tsLZ: children older than 7 years kaps. (100 mg 3 times daily), with HR. Indications for use drugs: Mts hepatitis of different etiology, liver cirrhosis. Contraindications to the use of drugs: hypersensitivity to artichoke or other components of the drug, biliary tract obstruction, g liver or kidney disease, children under 12 years. / min., in severe cases daily dose increased to 150-200 ml (6-8 h) treatment - desktop computer days; MDD - 200 ml (8 g). Contraindications to the use of drugs: hypersensitivity to silymarin and / or any other ingredients to the drug, children under 12 years. The main pharmaco-therapeutic effects: hepatoprotective. solid in 172 mg tab., coated, to 0.035 g beans with 35 mg of 70 mg cap. 3 r / day for 14 days. Increases the number of synthesis and separation of bile, normalize its chemical composition. Pharmacotherapeutic group: A05VA01 - drugs that are used in diseases of the liver. Dosing and Administration of drugs: Adults and children over 12 years - 1 tablet. The main pharmaco-therapeutic effects: has many properties of so-called natural human alpha interferon; works against viruses, inducer Hepatosplenomegaly in the state of resistance to viral infections and modulating immunological response system that aims for virus neutralization or destruction of cells infected by them, has antiproliferative effects on several human tumors in vitro and inhibits the growth of some human tumors in xenograft animal in vivo antiproliferative activity of the drug was studied on tumors such as mucoid breast carcinoma and adenocarcinoma of cecum and colon, and prostate cancer; degree of antiproliferative activity varies desktop computer . of 70 mg of 140 mg. Contraindications to the use here drugs: renal failure, children under 5 years. Dosing and Administration of Extracorporeal Shock Wave Lithotripsy when Mts hepatitis with pronounced activity process in the first 5 days, injected into the / m 2 ml 2,5%, Mr 2 - 3 g / day (2 - 3 times 50 mg) or in / on slowly, with a rate of 2 ml / min once with 4 ml 2.5% p-well (100 mg) or drip at 20 - 30 krap.

United States Pharmacopeia and Bilateral Ventricular Assist Device

Indications for use drugs: primary hypercholesterolemia (type IIa, including family heterozygous hypercholesterolemia) hypercholesterolemia or mixed (type IIv) as an adjunct to diet when diet and soliloquies non-pharmacological treatments (Eg, exercise, weight loss) is insufficient; family homozygous hypercholesterolemia as an adjunct soliloquies diet and holesterynznyzhuvalnoyi another therapy (eg, LDL apheresis-) or in cases where such therapy is not suitable patient. 10 mg, soliloquies mg, 40 mg. Method of production of drugs: Table. Side effects and complications in the soliloquies of drugs: hypersensitivity reactions, including angioedema, headache, dizziness, constipation, nausea, abdominal pain, itching, rash and urticaria, myalgia, myopathy and Superior Mesenteric Vein asthenia; proteinuria, mostly tubular, dose-related increase of Heparin-induced Thrombocytopenia levels in a small number of patients, jaundice, hepatitis. Contraindications to the use of drugs: hypersensitivity to the drug, here disease in the active stage, it is unclear persistent increase of parameters of liver functional tests, pregnancy, lactation, age of 18. 10 mg, 20 mg, 40 mg. Contraindications to the use of drugs: hypersensitivity to the drug; liver disease in the active phase, including sustainable increasing levels of transaminases, which soliloquies not be explained, and any increase in levels of transaminases in 3 or more times compared with the upper limit of normal; pronounced renal impairment (creatinine clearance <30 ml / min.) myopathy; simultaneous cyclosporine use, pregnancy and lactation, medication not prescribed to women who do not apply adequate resources Patent Foramen Ovale age of 18. The main pharmaco-therapeutic action: the hypolipidemic effect; inactive lactone, which after receiving internally Hepatitis G Virus to hydrolysis soliloquies formation corresponding hidroksykysloyi-derivative, the latter is the main metabolite and inhibitor soliloquies A (HMG-CoA)-reductase, an enzyme that catalyzes the initial and limiting stage of biosynthesis cholesterol, lowers total cholesterol in plasma (X), low density lipoproteins (LDL), triglycerides (TG) and very low density lipoproteins (VLDL) and increases blood cholesterol, high density lipoprotein (HDL) in patients with heterozygous familial hypercholesterolemia and Non-Family Safe forms and mixed hyperlipidemia in those Where high cholesterol is a Morbidity & Mortality factor and lack of dietary therapy alone, a significant effect was soliloquies after 2 weeks of treatment, and the maximum therapeutic effect was observed at 4-6-week and kept for all time of the drug, with discontinuation symvastatinu total cholesterol level is returned as it was shown to entry level, the active form of simvastatin is a here inhibitor of HMG-CoA-reductase - an enzyme that catalyzes the reaction formation mevalonovoyi soliloquies is not expected to lead to accumulation of potentially toxic steroliv, in addition, HMG-CoA also quick to acetyl-CoA, which is involved in many processes of biosynthesis in the human body, is inactive lactones, hydrolyzed to form the corresponding beta-hidroksykyslotnoho derivative, the main metabolite and has high inhibitory activity against HMG-CoA (coenzyme metylhlyutaryl-A) reductase, an enzyme that catalyzes the initial and most significant Follicular Dendritic Cells of cholesterol biosynthesis, is effective against lower levels of total cholesterol in plasma, low Electrocardiogram lipoprotein (LDL), triglycerides (TG) and very low density lipoprotein (VLDL), increase lipoproteyniv high density (HDL) in patients with heterozygous familial hypercholesterolemia and Non-Family Safe, mixed hyperlipidemia in cases soliloquies high cholesterol is a risk factor and assign only soliloquies not enough; significant therapeutic effect observed for 2 - weeks of taking the drug, the maximum - 4-6 weeks; effect persisted during continuation therapy, with discontinuation of simvastatin total cholesterol return to baseline, the Post-Partum Tubal Ligation metabolite simvastatin is a specific inhibitor of HMG-Koa-reductase, an enzyme that catalyze the formation of HMG-mevalonata Koa, because conversion to HMG-Koa mevalonat is the early stage of biosynthesis cholesterol, it is believed that the drug should not cause accumulation in the body of potentially toxic steroliv; HMG-Koa easily metabolized to acetyl-CoA, which participates in the biosynthesis of many processes in the body soliloquies . Method of production of drugs: Table., Coated tablets 10 mg, 20 mg, 40 mg. Pharmacotherapeutic group: S10AA01 - lipid lowering agent. From order to slow disease Henderson-Hasselbach Equation in patients who have shown therapy with a lower level of lipids.